October 1st, 2012 Medgadget Editors Vascular Surgery

Boston Scientific has received clearance to launch its Emerge Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Dilatation Catheter in the US. The device received EU clearance earlier this year.

The Emerge, designed for accessing difficult lesions within coronary arteries, is available in diameters of 1.5 mm to 4.0 mm and balloons in length from 8 mm to 30 mm.

Both the Monorail and OTW catheters are available with two distinct shaft technologies designed to provide versatility in addressing different clinical situations.  The “Push Technology” (1.5 mm) offers a single-segment inner shaft for enhanced pushability.  The “Workhorse Technology” (1.5 mm to 4.0 mm) features a bi-segment inner shaft designed for excellent deliverability without sacrificing push.

“The Emerge Balloon Catheter combines Boston Scientific’s innovative balloon technologies into a single platform,” said J. Tift Mann, III, M.D., at Wake Heart & Vascular, Raleigh, North Carolina.  “The result is exceptional deliverability and reliable performance in a wide range of anatomy and lesion types.”

Press release: Boston Scientific Launches Emergeâ„¢ PTCA Balloon Dilatation Catheter in the U.S.

Product page: Emerge PTCA Dilatation Catheter

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.